M&R Capital Management’s Celgene Corp CELG Stock Holding History

M&R Capital Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-400	Closed	-$39K	–	532
2019 Q3	$39K	Hold	400	–	–	0.01%	296
2019 Q2	$36K	Hold	400	–	–	0.01%	310
2019 Q1	$37K	Hold	400	–	–	0.01%	311
2018 Q4	$25K	Hold	400	–	–	0.01%	337
2018 Q3	$35K	Hold	400	–	–	0.01%	328
2018 Q2	$31K	Sell	400 -700	-64%	-$58.1K	0.01%	332
2018 Q1	$98K	Sell	1,100 -465	-30%	-$44.6K	0.02%	231
2017 Q4	$163K	Sell	1,565 -550	-26%	-$62.1K	0.04%	201
2017 Q3	$308K	Hold	2,115	–	–	0.07%	151
2017 Q2	$276K	Sell	2,115 -2,305	-52%	-$282K	0.07%	158
2017 Q1	$549K	Buy	4,420 +100	+2%	+$12K	0.14%	111
2016 Q4	$500K	Sell	4,320 -600	-12%	-$66.8K	0.14%	118
2016 Q3	$514K	Buy	4,920 +200	+4%	+$21.6K	0.15%	112
2016 Q2	$465K	Buy	4,720 +40	+0.9%	+$4.14K	0.14%	115
2016 Q1	$468K	Buy	4,680 +250	+6%	+$25.7K	0.14%	115
2015 Q4	$531K	Buy	4,430 +1,400	+46%	+$162K	0.15%	109
2015 Q3	$328K	Sell	3,030 -200	-6%	-$24.8K	0.09%	141
2015 Q2	$374K	Buy	3,230 +150	+5%	+$17.1K	0.09%	150
2015 Q1	$355K	Sell	3,080 -50	-2%	-$5.97K	0.08%	157
2014 Q4	$350K	Buy	3,130 +630	+25%	+$66.4K	0.08%	155
2014 Q3	$237K	Sell	2,500 -400	-14%	-$36.1K	0.06%	190
2014 Q2	$249K	Buy	+2,900	New	+$221K	0.06%	182

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

M&R Capital Management's CELG Position: Q4 2019 in Review

M&R Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 400 shares — an estimated $39K sold.

M&R Capital Management first reported a position in CELG in Q2 2014 and held it in 22 quarters. The position peaked at $549K in Q1 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

M&R Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
M&R Capital Management sold 400 Celgene Corp shares in Q4 2019, an estimated $39K.
M&R Capital Management first reported a position in Celgene Corp in Q2 2014 and held it in 22 quarters.
M&R Capital Management's Celgene Corp position peaked at $549K in Q1 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on M&R Capital Management's 13F filing for Q4 2019, filed 7 Jan 2020.